Back to top

Analyst Blog

Watson Pharmaceuticals Inc. along with Columbia Laboratories Inc. recently announced that the latter’s New Drug Application (NDA) for Prochieve (progesterone gel) has been accepted by the US Food and Drug Administration (FDA). The companies are looking to get Prochieve approved for the reduction of preterm birth in women with short uterine cervical length in the mid-trimester of pregnancy.

However, Columbia Labs has withdrawn its request for priority review of the drug, following which the FDA has set a target date of February 26, 2012 for Prochieve.

In July last year, Watson Pharma had acquired the US rights to Columbia Labs’ products Prochieve and Crinone. According to the purchase and collaboration agreement, following the FDA’s acceptance of the Prochieve NDA, Watson Pharma will have to make a $5 million milestone payment to Columbia Labs.

For Crinone, which is indicated for the treatment of infertility in women, Columbia Labs receives royalties on net sales made by Watson Pharma. Outside the US, Crinone is marketed by Merck KGaA (MKGAF).

Watson Pharma had launched Crinone in 2010, along with ella and Trelstar. Ella is an emergency contraceptive which helps in preventing pregnancies for up to five days after unprotected intercourse, whereas Trelstar is marketed for the palliative treatment of advanced prostate cancer.

Moreover, Watson Pharma also gained approval for an oral contraceptive in December 2010. The product, which is licensed from Warner Chilcott plc , is a chewable 25-microgram ethinyl estradiol product with a 24/4 dosing regimen.

We currently have a Zacks #2 Rank (short-term Buy rating) on Watson Pharma. We believe that the company’s cost saving initiative and new product launches, both branded and generic, will help drive growth.

In the long-term, we have a Neutral recommendation on the company.

Please login to Zacks.com or register to post a comment.

New to Zacks?

Start Here

Zacks Investment Research

Close

Are you a new Zacks Member or a visitor to Zacks.com?

Top Zacks Features

My Portfolio Tracker

Is it Time to Sell?

One of the most important steps you can take today is to set up your portfolio tracker on Zacks.com. Once you do, you'll be notified of major events affecting your stocks and/or funds with daily email alerts.

More Zacks Resources

Zacks Rank Home - Evaluate your stocks and use the Zacks Rank to eliminate the losers and keep the winners.

Mutual Fund Rank Home - Evaluate your funds with the Mutual Fund Rank for both your personal and retirement funds.

Stock/Mutual Fund Screening - Find better stocks and mutual funds. The ones most likely to beat the market and provide a positive return.

My Portfolio - Track your Portfolio and find out where your stocks/mutual funds stack up with the Zacks Rank.

Zacks #1 Rank Top Movers for Zacks #1 Rank Top Movers

Company Symbol Price %Chg
SOUTHWEST A… LUV 31.85 +1.95%
PLANAR SYST… PLNR 4.30 +1.90%
CHINA BIOLO… CBPO 47.14 +1.64%
MALLINCKROD… MNK 71.99 +1.51%
GILEAD SCIE… GILD 103.27 +0.98%